These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34879285)

  • 21. Global LC-MS/MS targeted metabolomics using a combination of HILIC and RP LC separation modes on an organic monolithic column based on 1-vinyl-1,2,4-triazole.
    Basov NV; Rogachev AD; Aleshkova MA; Gaisler EV; Sotnikova YS; Patrushev YV; Tolstikova TG; Yarovaya OI; Pokrovsky AG; Salakhutdinov NF
    Talanta; 2024 Jan; 267():125168. PubMed ID: 37708770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enantioselectivity Effects in Clinical Metabolomics and Lipidomics.
    Oliveira RV; Simionato AVC; Cass QB
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unbiased Lipidomics and Metabolomics of Human Brain Samples.
    Astarita G; Stocchero M; Paglia G
    Methods Mol Biol; 2018; 1750():255-269. PubMed ID: 29512078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive and simultaneous coverage of lipid and polar metabolites for endogenous cellular metabolomics using HILIC-TOF-MS.
    Fei F; Bowdish DM; McCarry BE
    Anal Bioanal Chem; 2014 Jun; 406(15):3723-33. PubMed ID: 24714971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current state-of-the-art of nontargeted metabolomics based on liquid chromatography-mass spectrometry with special emphasis in clinical applications.
    Yin P; Xu G
    J Chromatogr A; 2014 Dec; 1374():1-13. PubMed ID: 25444251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of Mobile Phase Modifiers for Fast LC-MS-Based Untargeted Metabolomics and Lipidomics.
    Cajka T; Hricko J; Rudl Kulhava L; Paucova M; Novakova M; Kuda O
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography-mass spectrometry and hydrophilic interaction liquid chromatography-mass spectrometry.
    Wolrab D; Chocholoušková M; Jirásko R; Peterka O; Holčapek M
    Anal Bioanal Chem; 2020 Apr; 412(10):2375-2388. PubMed ID: 32078000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of mass spectrometry-based targeted and non-targeted lipidomics.
    Lee HC; Yokomizo T
    Biochem Biophys Res Commun; 2018 Oct; 504(3):576-581. PubMed ID: 29534960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical assessment of chromatographic metadata in publicly available metabolomics data repositories.
    Harrieder EM; Kretschmer F; Dunn W; Böcker S; Witting M
    Metabolomics; 2022 Nov; 18(12):97. PubMed ID: 36436113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HILIC-MS for metabolomics: An attractive and complementary approach to RPLC-MS.
    Tang DQ; Zou L; Yin XX; Ong CN
    Mass Spectrom Rev; 2016 Sep; 35(5):574-600. PubMed ID: 25284160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Miniaturized Two-Dimensional Heart Cutting for LC-MS-Based Metabolomics.
    Orlandi C; Jacques C; Duplan H; Debrauwer L; Jamin EL
    Anal Chem; 2023 Feb; 95(5):2822-2831. PubMed ID: 36715352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a rapid profiling method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS.
    King AM; Mullin LG; Wilson ID; Coen M; Rainville PD; Plumb RS; Gethings LA; Maker G; Trengove R
    Metabolomics; 2019 Jan; 15(2):17. PubMed ID: 30830424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross platform solutions to improve the zebrafish polar metabolome coverage using LC-QTOF MS: Optimization of separation mechanisms, solvent additives, and resuspension solvents.
    Xu M; Legradi J; Leonards P
    Talanta; 2021 Nov; 234():122688. PubMed ID: 34364485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipidomics by HILIC-Ion Mobility-Mass Spectrometry.
    Li A; Hines KM; Xu L
    Methods Mol Biol; 2020; 2084():119-132. PubMed ID: 31729657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrahigh-Performance capillary liquid chromatography-mass spectrometry at 35 kpsi for separation of lipids.
    Sorensen MJ; Miller KE; Jorgenson JW; Kennedy RT
    J Chromatogr A; 2020 Jan; 1611():460575. PubMed ID: 31607445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LC-MS-based metabolomics.
    Bajad S; Shulaev V
    Methods Mol Biol; 2011; 708():213-28. PubMed ID: 21207293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison.
    Leuthold P; Schaeffeler E; Winter S; Büttner F; Hofmann U; Mürdter TE; Rausch S; Sonntag D; Wahrheit J; Fend F; Hennenlotter J; Bedke J; Schwab M; Haag M
    J Proteome Res; 2017 Feb; 16(2):933-944. PubMed ID: 27992229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-step lipid extraction for plasma lipidomics analysis by liquid chromatography mass spectrometry.
    Satomi Y; Hirayama M; Kobayashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():93-100. PubMed ID: 28850891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of human plasma and urine sample preparation for reproducible and high-throughput UHPLC-MS clinical metabolic phenotyping.
    Southam AD; Haglington LD; Najdekr L; Jankevics A; Weber RJM; Dunn WB
    Analyst; 2020 Oct; 145(20):6511-6523. PubMed ID: 32760982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.